1 results match your criteria: "The University of Hong Kong Shenz hen Hospital[Affiliation]"
Acrodermatitis continua of Hallopeau with insufficient response to ixekizumab and infliximab, successfully treated with a combination of ustekinumab and tofacitinib.
Eur J Dermatol
April 2023
Department of Dermatology, The University of Hong Kong Shenz hen Hospital, Shenzhen, China 518053.